~~<i id='C5AF8C769D'><strike id='C5AF8C769D'><tt id='C5AF8C769D'><pre id='C5AF8C769D'></pre></tt></strike></i>~~

Home» Wikipedia» comprehensive

comprehensive

author：fashion 2025-09-29 05:17:03 Page View：28

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Illumina names Agilent executive as new CEO
Next article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban

explore

Dobbs anniversary: the lost opportunity of abortion as health care

NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

4:01FormerPresidentDonaldTrumpwavesashestepsoffhisplaneatRonaldReaganWashingtonNationalAirport,Aug.3

Medical records are filled with copy

AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

The 10 drugs up first for Medicare price negotiation

PresidentBiden'sWhiteHouseannouncedthefirst10medicinesthatwillbeupfirstinitsnewdrugpricenegotiationp